Professor of Clinical Oncology
- Clinical Director of the Oxford Institute for Radiation Oncology
We aim to deliver a step change in the effectiveness of radiotherapy through the evaluation of novel scientific approaches derived from the Institute's scientists in hypothesis driven clinical trials.
Tim Maughan was appointed Professor of Clinical Oncology and Clinical Director of the Oxford Institute for Radiation Oncology in the Department of Oncology in 2011. Previously, Tim worked as an NHS consultant Clinical Oncologist in Cardiff, becoming Professor of Cancer Studies in 2007. During that time, he established the first clinical research network, the Wales Cancer Trials Network, and subsequently the development of the clinical research networks across the UK.
He was the founding chair of the NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad), which has a broad remit to enhance radiotherapy research in the UK.
Sjoquist KM. et al, (2018), J Natl Cancer Inst, 110, 638 - 648
Tanskanen T. et al, (2018), Int J Cancer, 142, 540 - 546
Advanced Radiotherapy Technologies Network in the UK (ART-NET) - focus on lung cancer
Brown S. et al, (2018), LUNG CANCER, 115, S60 - S60
HER1-3 inhibition in patients with colorectal cancer that is wild-type for BRAF, PIK3CA, KRAS, and NRAS mutations (FOCUS-4D): first results from the multi-arm multi-stage phase II/III FOCUS-4 randomised trial
Adams R. et al, (2017), The Lancet Gastroenterology & Hepatology
Hordern J. et al, (2017), Biomed Hub, 2